Lipigon Pharmaceuticals AB's market cap is currently €5.37M. The company's EPS TTM is €-0.004198650999999999; its P/E ratio is ―; Lipigon Pharmaceuticals AB is scheduled to report earnings on May 27, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in SEK
Lipigon Pharmaceuticals AB Earnings and Revenue History
